Marcus Lippold’s Post

At Goodland Pharma, our journey began with a profound passion for the triumphs of life science. Founded by visionaries deeply entrenched in the industry, we've cultivated global teams that have played pivotal roles in countless scientific breakthroughs. What sets us apart? Our seasoned expertise isn't just surface-level – it delves deep into your world, comprehending the intricate nuances of regulations and the critical factors that drive clinical trial success. Get started here: https://lnkd.in/g_z8FmWD #GoodlandPharma #TailoredSolutions #LifeScience #ClinicalTrials

Let's meet at #DOT to understand your drug discovery challenges & how we at Jubilant can accelerate your drug discovery journey seamlessly!

With wise leadership comes the right man, and thus, success is merely a matter of time.

Pharming announces $66.1m public cash offer to acquire Abliva AB https://lnkd.in/eGzaBZ_d Pharming Group N.V. Abliva AB Sijmen De Vries Michael Levitan More European life science business news at [LSE] Life-Sciences-Europe.com __

✨ 2024: A Year of Transformation for CureVac ✨ As we close the chapter on 2024, we reflect on a year of bold decisions, transformative changes, and significant progress. It was a year of challenges, but also one that strengthened our foundation for a brighter and more agile future. This is "CureVac 2.0"—focused, flexible, and confident. Here’s what we accomplished: 🔹 Transformative Licensing Agreement with GSK A landmark deal that fortified our financial position and unlocked new strategic opportunities for innovation and growth. 🔹 Making Tough but Necessary Changes To ensure long-term sustainability, we realigned and resized our organization. While parting with valued colleagues was difficult, we are deeply grateful for their contributions and wish them every success. 🔹 Refocusing on Core Strengths We sharpened our focus on advancing groundbreaking research, driving technology innovation, and progressing early development in Oncology and Infectious Diseases. 🔹 Advancing Our Pipeline 2024 saw major progress in our internal programs for Oncology and Infectious Diseases. Our collaboration with GSK gained momentum, with positive developments and strong validation of our mRNA platform. 🔹 Strengthening Our Leadership Team We welcomed two seasoned industry leaders: Thaminda Ramanayake as Chief Business Officer (CBO) Axel Malkomes as Chief Financial Officer (CFO) Their expertise will accelerate strategic growth and financial excellence as we move forward. 💡 None of these achievements would have been possible without the passion, dedication, and resilience of our team. As we step into 2025, CureVac is poised for continued growth and innovation in mRNA-based therapies. 🌟 Thank you to everyone who made 2024 a transformative year. Let’s keep breaking boundaries and advancing the future of medicine—together.

🚀 Medistri SA Certified as a Corporate Citizenship At Medistri, we believe our commitments are both ambitious and necessary. To achieve our objectives, we focus on scalable innovation. Designing and implementing new technologies, mobilising financing structures, and rapidly deploying renewable energy. The “Entreprise Citoyenne TM” label is awarded on the basis of prior certification to ISO 9001 (quality management system) and ISO 14001 (environmental management system) standards. A “Entreprise Citoyenne” is one that takes social and environmental considerations into account in its activities and in its relations. It is therefore an organization whose economic, environmental and social goals coexist, while demonstrating that the pursuit of financial profit is not its sole objective. 👉 Carrying the label enables differentiation and better positioning, while guaranteeing consumers of the company's commitment to sustainable development and continuous improvement. ISO 14001: ISO 14001 is an internationally recognized standard for environmental management systems (EMS). It provides a framework for organizations to design and implement an EMS and continually improve their environmental performance. By adopting this standard, organizations can ensure that they are taking proactive measures to reduce their environmental footprint, comply with existing legal requirements, and achieve their environmental objectives. The framework provided by this standard covers various aspects, from resource use and waste management to monitoring environmental performance and involving stakeholders in environmental commitments. Medistri is the largest independent sterilisation company in Europe and its mission is to facilitate innovaton in the global health sector. Since its foundation in 2006, the company has continued to grow into one of the leading providers of contract sterilization & laboratory services for healthcare companies. Medistri has grown to become a dependable partner for businesses in the pharmaceutical, medical device, aerospace, and biotechnology sectors. 🎯 Medistri's headquarters are located in Domdidier, Switzerland. For more information, please visit https://buff.ly/3UXa4Na or contact contact@medistri.swiss. 🌐 Learn more: buff.ly/4cQmflI - The Medistri Team #Medistri #Repost

Joining the Pharmaron team has been an incredible journey. Reflecting on my time here, I'm reminded of the profound symbolism embedded in the name "Pharmaron" itself. In Chinese, Pharmaron (康龙化成) embodies key values and principles that resonate deeply with our mission and vision. Let's delve into its meaning: Health (康): At Pharmaron, our foremost commitment is to improve global health outcomes. Every project, every innovation, and every endeavour is driven by the desire to enhance the well-being of individuals worldwide. Dragon (龙): The dragon is not just a mythical creature; it's a symbol of power, strength, and vitality in Chinese culture. It represents the vigour and dynamism that characterizes Pharmaron's approach to business—a relentless pursuit of excellence and success. Transformation/Chemistry (化): Transformation lies at the heart of what we do. Through groundbreaking research, innovative solutions, and strategic partnerships, we continuously strive to transform the landscape of drug discovery and development. Our expertise in chemistry serves as the foundation for these transformative endeavours, driving progress and innovation in the pharmaceutical industry. Success (成): Success is not merely an outcome; it's a journey marked by integrity, ethics, and dedication. At Pharmaron, we define success not only by achieving our goals but also by upholding the highest standards of ethical conduct, fostering a culture of trust and collaboration, and making a positive impact on society. As I reflect on the significance of Pharmaron's name, I'm reminded of the profound responsibility and privilege we have as stewards of health, innovation, and progress. Together, let's continue to embrace these values, drive positive change, and shape a brighter future for healthcare. And speaking of Pharmaron, meet our little mascot Kangzai; The Ying Dragon! 🐲 Isn't he adorable? He symbolizes the spirit of resilience, determination, and endless possibilities that inspire us at Pharmaron every day. #Pharmaron #Healthcare #Innovation #DrugDiscovery #TransformativeChemistry #Success #TeamWork

At BioStratiq, we consistently monitor and analyze transaction volumes in the life sciences sector. As Q3 2024 brings encouraging developments in Sweden’s healthcare and medical technology sectors, notable strategic deals in biotech and regional healthcare services are driving growth. Despite challenges like valuation gaps and high interest rates, investor appetite remains strong. With the BIO-Europe life science dealmaking conference taking place in Stockholm from November 4-6, the timing is perfect for life sciences M&A to gain further momentum. We’re hopeful this event will positively impact Swedish transaction activities as interest rate cuts are expected to stimulate even more deal-making in Q4. At BioStratiq, we are excited about these opportunities and remain committed to supporting our clients through tailored transaction advisory, valuations, and deal analysis. #Pharma #Biotech #Medtech #LifeSciences #Valuation #Licensing #BusinessDevelopment #BIOEurope

Carbon Connects by Carbon Global with Dr. Goran Martinovic 🚨 Healthcare agencies don't miss this one, Goran delves into how he chooses agencies and what makes agencies stand out 🚨 In this episode: - The transformative changes in medical affairs and the overall healthcare system over the past three years. - The impact of technology and artificial intelligence on pharmaceuticals and patient care. - The importance of merging clinical evidence with physician judgment and expert opinions in decision-making. - Strategies for creating a patient-centric healthcare environment amid evolving digital landscapes. - Insights into the future workforce in pharma, emphasizing the balance between technology and human elements. - How Goran looks for new agencies and what influences his decision to choose the right ones. - Up next: The wonderful Henriette Lonkvist at Ferring Pharmaceuticals #carbonconnects #healthcare https://lnkd.in/e9AU_Zcs

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages https://lnkd.in/gKKKNv85 Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life sciences companies. The post $600M+ Credit Firm Targets Life-Sci Companies in Later Stages appeared first on GEN [...]